Cargando…

UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension

BACKGROUND: Left ventricular diastolic dysfunction, an early stage in the pathogenesis of heart failure with preserved ejection fraction, is exacerbated by joint exposure to hypertension and obesity; however, the molecular mechanisms involved remain uncertain. The mitochondrial UCP3 (uncoupling prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xu, Ashraf, Sadia, Ashraf, Nadia, Harmancey, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649532/
https://www.ncbi.nlm.nih.gov/pubmed/34533037
http://dx.doi.org/10.1161/JAHA.121.022556
_version_ 1784611016235024384
author Chen, Xu
Ashraf, Sadia
Ashraf, Nadia
Harmancey, Romain
author_facet Chen, Xu
Ashraf, Sadia
Ashraf, Nadia
Harmancey, Romain
author_sort Chen, Xu
collection PubMed
description BACKGROUND: Left ventricular diastolic dysfunction, an early stage in the pathogenesis of heart failure with preserved ejection fraction, is exacerbated by joint exposure to hypertension and obesity; however, the molecular mechanisms involved remain uncertain. The mitochondrial UCP3 (uncoupling protein 3) is downregulated in the heart with obesity. Here, we used a rat model of UCP3 haploinsufficiency (ucp3(+/‐)) to test the hypothesis that decreased UCP3 promotes left ventricular diastolic dysfunction during hypertension. METHODS AND RESULTS: Ucp3(+/‐) rats and ucp3(+/+) littermates fed a high‐salt diet (HS; 2% NaCl) and treated with angiotensin II (190 ng/kg per min for 28 days) experienced a similar rise in blood pressure (158±4 versus 155±7 mm Hg). However, UCP3 insufficiency worsened diastolic dysfunction according to echocardiographic assessment of left ventricular filling pressures (E/e’; 18.8±1.0 versus 14.9±0.6; P<0.05) and the isovolumic relaxation time (24.7±0.6 versus 21.3±0.5 ms; P<0.05), as well as invasive monitoring of the diastolic time constant (Tau; 15.5±0.8 versus 12.7±0.2 ms; P<0.05). Exercise tolerance on a treadmill also decreased for HS/angiotensin II‐treated ucp3(+/‐) rats. Histological and molecular analyses further revealed that UCP3 insufficiency accelerated left ventricular concentric remodeling, detrimental interstitial matrix remodeling, and fetal gene reprogramming during hypertension. Moreover, UCP3 insufficiency increased oxidative stress and led to greater impairment of protein kinase G signaling. CONCLUSIONS: Our findings identified UCP3 insufficiency as a cause for increased incidence of left ventricular diastolic dysfunction during hypertension. The results add further support to the use of antioxidants targeting mitochondrial reactive oxygen species as an adjuvant therapy for preventing heart failure with preserved ejection fraction in individuals with obesity.
format Online
Article
Text
id pubmed-8649532
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86495322021-12-20 UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension Chen, Xu Ashraf, Sadia Ashraf, Nadia Harmancey, Romain J Am Heart Assoc Original Research BACKGROUND: Left ventricular diastolic dysfunction, an early stage in the pathogenesis of heart failure with preserved ejection fraction, is exacerbated by joint exposure to hypertension and obesity; however, the molecular mechanisms involved remain uncertain. The mitochondrial UCP3 (uncoupling protein 3) is downregulated in the heart with obesity. Here, we used a rat model of UCP3 haploinsufficiency (ucp3(+/‐)) to test the hypothesis that decreased UCP3 promotes left ventricular diastolic dysfunction during hypertension. METHODS AND RESULTS: Ucp3(+/‐) rats and ucp3(+/+) littermates fed a high‐salt diet (HS; 2% NaCl) and treated with angiotensin II (190 ng/kg per min for 28 days) experienced a similar rise in blood pressure (158±4 versus 155±7 mm Hg). However, UCP3 insufficiency worsened diastolic dysfunction according to echocardiographic assessment of left ventricular filling pressures (E/e’; 18.8±1.0 versus 14.9±0.6; P<0.05) and the isovolumic relaxation time (24.7±0.6 versus 21.3±0.5 ms; P<0.05), as well as invasive monitoring of the diastolic time constant (Tau; 15.5±0.8 versus 12.7±0.2 ms; P<0.05). Exercise tolerance on a treadmill also decreased for HS/angiotensin II‐treated ucp3(+/‐) rats. Histological and molecular analyses further revealed that UCP3 insufficiency accelerated left ventricular concentric remodeling, detrimental interstitial matrix remodeling, and fetal gene reprogramming during hypertension. Moreover, UCP3 insufficiency increased oxidative stress and led to greater impairment of protein kinase G signaling. CONCLUSIONS: Our findings identified UCP3 insufficiency as a cause for increased incidence of left ventricular diastolic dysfunction during hypertension. The results add further support to the use of antioxidants targeting mitochondrial reactive oxygen species as an adjuvant therapy for preventing heart failure with preserved ejection fraction in individuals with obesity. John Wiley and Sons Inc. 2021-09-17 /pmc/articles/PMC8649532/ /pubmed/34533037 http://dx.doi.org/10.1161/JAHA.121.022556 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Chen, Xu
Ashraf, Sadia
Ashraf, Nadia
Harmancey, Romain
UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension
title UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension
title_full UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension
title_fullStr UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension
title_full_unstemmed UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension
title_short UCP3 (Uncoupling Protein 3) Insufficiency Exacerbates Left Ventricular Diastolic Dysfunction During Angiotensin II‐Induced Hypertension
title_sort ucp3 (uncoupling protein 3) insufficiency exacerbates left ventricular diastolic dysfunction during angiotensin ii‐induced hypertension
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649532/
https://www.ncbi.nlm.nih.gov/pubmed/34533037
http://dx.doi.org/10.1161/JAHA.121.022556
work_keys_str_mv AT chenxu ucp3uncouplingprotein3insufficiencyexacerbatesleftventriculardiastolicdysfunctionduringangiotensiniiinducedhypertension
AT ashrafsadia ucp3uncouplingprotein3insufficiencyexacerbatesleftventriculardiastolicdysfunctionduringangiotensiniiinducedhypertension
AT ashrafnadia ucp3uncouplingprotein3insufficiencyexacerbatesleftventriculardiastolicdysfunctionduringangiotensiniiinducedhypertension
AT harmanceyromain ucp3uncouplingprotein3insufficiencyexacerbatesleftventriculardiastolicdysfunctionduringangiotensiniiinducedhypertension